October 5, 2021 — A promising radionuclide treatment may offer new therapeutic options for breast cancer patients, according to research published in The Journal of Nuclear Medicine. The treatment combines radioactive iodine therapy with single-domain antibodies that target the human epidermal growth factor receptor type 2 (
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now